Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.
Ferreri AJ, Cwynarski K, Pulczynski E, Ponzoni M, Deckert M, Politi LS, Torri V, Fox CP, Rosée PL, Schorb E, Ambrosetti A, Roth A, Hemmaway C, Ferrari A, Linton KM, Rudà R, Binder M, Pukrop T, Balzarotti M, Fabbri A, Johnson P, Gørløv JS, Hess G, Panse J, Pisani F, Tucci A, Stilgenbauer S, Hertenstein B, Keller U, Krause SW, Levis A, Schmoll HJ, Cavalli F, Finke J, Reni M, Zucca E, Illerhaus G; International Extranodal Lymphoma Study Group (IELSG).
Lancet Haematol. 2016 May;3(5):e217-27. doi: 10.1016/S2352-3026(16)00036-3. Epub 2016 Apr 6.
Central nervous system toxicities of chemotherapeutic agents.
Peddi PF, Peddi S, Santos ES, Morgensztern D.
Expert Rev Anticancer Ther. 2014 Jul;14(7):857-63. doi: 10.1586/14737140.2014.911089. Epub 2014 Apr 21.
Combination chemotherapy in malignant diseases.
Fairley GH.
J R Coll Physicians Lond. 1971 Jan;5(2):167-77.
Efficacy and Toxicity of Intrathecal Liposomal Cytarabine in First-line Therapy of Childhood Acute Lymphoblastic Leukemia.
Levinsen M, Harila-Saari A, Grell K, Jonsson OG, Taskinen M, Abrahamsson J, Vettenranta K, Åsberg A, Risteli J, Heldrup J, Schmiegelow K.
J Pediatr Hematol Oncol. 2016 Nov;38(8):602-609. doi: 10.1097/MPH.0000000000000642.
Neurologic toxicities of cancer therapies.
Cavaliere R, Schiff D.
Curr Neurol Neurosci Rep. 2006 May;6(3):218-26. doi: 10.1007/s11910-006-0009-8.
Clinical management of cytotoxic drug overdose.
Thomas LL, Mertens MJ, von dem Borne AE, van Boxtel CJ, Veenhof CH, Veies EP.
Med Toxicol Adverse Drug Exp. 1988 Jul-Aug;3(4):253-63. doi: 10.1007/BF03259938.
Standard therapy of advanced Hodgkin lymphoma.
Kuruvilla J.
Hematology Am Soc Hematol Educ Program. 2009:497-506. doi: 10.1182/asheducation-2009.1.497.
Leukemia in arsenic poisoning.
Kjeldsberg CR, Ward HP.
Ann Intern Med. 1972 Dec;77(6):935-7. doi: 10.7326/0003-4819-77-6-935.
[Treatment strategy of Hodgkin lymphoma].
Nagai H.
Rinsho Ketsueki. 2014 Oct;55(10):1941-51.
Idiopathic hyperammonemic encephalopathy secondary to gemcitabine-cisplatin treatment.
Verkerk K, Otten HM, Huitema ADR.
Cancer Chemother Pharmacol. 2022 Nov;90(5):417-419. doi: 10.1007/s00280-022-04476-6. Epub 2022 Sep 20.
